Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2012 Jan 18;12(Suppl 1):S2. doi: 10.1186/1471-2180-12-S1-S2

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

Copyright ©2012 Chouaia et al; licensee BioMed Central Ltd.

This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

PMC Copyright notice

Effects of rifampicin on larval development: the apparition rate of pupae is similar between non treated groups and rifampicin treated groups supplemented with a rifampicin-resistant Asaia. The average cumulative number of pupae appearance, in relation with time, is reported for three different treatments. C: no treatment; A: rifampicin at 120 μg ml^-1; Ar: rifampicin at 120 μg ml^-1 plus rifampicin-resistant Asaia. The X-axis reports the number of days, starting from day seven, and the Y-axis reports the number of the pupae. The number of pupae at each day results from the sum of the pupae appeared at that day and the number of pupae counted in the days before.